Chiara Carlomagno
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 35
- Cancer Treatment and Pharmacology 25
- HER2/EGFR in Cancer Research 12
- Colorectal Cancer Surgical Treatments 7
- Cancer Research top 1%
- Breast Cancer Treatment Studies 12
- Hepatology top 2%
-
- Genetic factors in colorectal cancer 10
-
- Gastric Cancer Management and Outcomes 17
-
- Colorectal and Anal Carcinomas 10
- Co-authors
- Sabino De PlacidoMichelino De LaurentiisSara LonardiStefano PepeGianluca TomaselloSilvana ChiaraAlberto ZaniboniAlfredo Falcone
- Cited by
- OncologyCancer ResearchHepatology
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (11 papers)Cancer (1 paper)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Chiara Carlomagno
96 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 3.4k
- Cancer Research 1.2k
- Hepatology 516
- Pathology and Forensic Medicine 805
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Chiara Carlomagno
This map shows the geographic impact of Chiara Carlomagno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Carlomagno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Carlomagno more than expected).
Fields of papers citing papers by Chiara Carlomagno
This network shows the impact of papers produced by Chiara Carlomagno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Carlomagno. The network helps show where Chiara Carlomagno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chiara Carlomagno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2021 | 37 | |
| 3 | 2021 | 0 | |
| 4 | 2018 | 3 | |
| 5 | 2017 | 1 | |
| 6 | 2014 | 22 | |
| 7 | 2013 | 5 | |
| 8 | 2012 | 91 | |
| 9 | 2011 | 140 | |
| 10 | 2011 | 65 | |
| 11 | 2007 | 8 | |
| 12 | 2005 | 66 | |
| 13 | Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. | 2003 | 101 |
| 14 | 2002 | 2 | |
| 15 | Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up. | 1999 | 10 |
| 16 | 1996 | 328 | |
| 17 | 1995 | 28 | |
| 18 | 1995 | 4 | |
| 19 | 1995 | 156 | |
| 20 | 1990 | 24 |
About Chiara Carlomagno
Chiara Carlomagno is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 99 papers that have together received 4.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (35 papers), Cancer Treatment and Pharmacology (25 papers), Gastric Cancer Management and Outcomes (17 papers), HER2/EGFR in Cancer Research (12 papers), Breast Cancer Treatment Studies (12 papers), Colorectal and Anal Carcinomas (10 papers), Genetic factors in colorectal cancer (10 papers) and Colorectal Cancer Surgical Treatments (7 papers). The work is most often cited by research in Oncology (3.4k citations), Cancer Research (1.2k citations) and Hepatology (516 citations). Chiara Carlomagno has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Sabino De Placido, Michelino De Laurentiis, Sara Lonardi, Stefano Pepe, Gianluca Tomasello, Silvana Chiara, Alberto Zaniboni, Alfredo Falcone, Fotios Loupakis and Giuseppe Tonini. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.